Microsoft Showcases Paige’s Alba as Transformative AI in Cancer Diagnostics at HLTH 2024
Paige, a leader in next-generation AI technology, has announced that its foundation models will be showcased by Microsoft at the HLTH 2024 conference in Las Vegas. On October 21st, Matt Lungren, MD and Chief Scientific Officer of Microsoft Health &…
Wysa Launches Multilingual AI Initiative for Mental Health Support
Wysa, a global leader in AI-driven mental health support, has announced the launch of the Safety Assessment for LLMs in Mental Health (SAFE-LMH) initiative. Unveiled on World Mental Health Day, this groundbreaking initiative aims to create a unique platform for…
MiLaboratories Raises $10 Million in Series A Funding for Genomic Research
MiLaboratories, a leader in computational biology innovation, is excited to announce the successful completion of its Series A funding round, led by Madrid-based Kfund, with additional support from Speedinvest and other notable international investors. This funding milestone coincides with the…
Amprion Secures $15M in Funding to Advance Neurologic Diagnostics
Amprion, a global leader in neurodegenerative disorder diagnostics, has announced the successful initial close of $6 million in its $15 million Series B financing round. The round was led by Formation Venture Engineering (FVE), with participation from Eli Lilly and…
COPE Health Solutions and ACHESC Partner for Educational Development in Southern California
COPE Health Solutions (CHS), a national tech-enabled services firm that supports health plans and providers in risk arrangements, has announced a three-year partnership with the American College of Healthcare Executives of Southern California (ACHESC). This collaboration aims to improve healthcare…
Arcus Biosciences to Present ARC-20 Study Data at 2024 EORTC-NCI-AACR Symposium
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on cancer therapies, has announced the acceptance of four abstracts for the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, taking place from October 23-25, 2024, in Barcelona, Spain. The…
Siemens Healthineers Co-Leads EU Stroke Care Improvement Project
Siemens Healthineers is collaborating with over 20 industry and public partners, including seven leading stroke hospitals, to enhance stroke management across Europe. The five-year UMBRELLA project, with a total budget of €26.9 million, is partly funded by the Innovative Health…
HCA Healthcare Donates $1 Million for Hurricane Helene Relief in North Carolina
HCA Healthcare, Inc. (NYSE: HCA), a leading healthcare provider in the U.S., has announced a $1 million donation to support Hurricane Helene relief efforts in North Carolina through community organizations. On September 26, Hurricane Helene made landfall as a powerful…
Aetna’s 2025 Medicare Plans Prioritize Key Member Health Needs
Aetna®, a CVS Health® company, has announced its 2025 Medicare products, focusing on essential benefits that enhance members’ overall health. The offerings include affordable Medicare Advantage (MA) plans featuring $0 monthly premiums, $0 copays for primary care visits, and $0…
Elevance Health’s 2025 Medicare Advantage Plans Overview
Elevance Health (NYSE: ELV) has announced its affiliated health plans will offer flexible Medicare Advantage options with personalized supplemental benefits aimed at enhancing the overall health of nearly 40.3 million Medicare-eligible consumers across 23 states and Puerto Rico. These plans…
UnitedHealthcare Invests $335,000 to Boost Idaho Health Care Workforce and Access
UnitedHealthcare has announced a $335,000 funding initiative aimed at enhancing healthcare access in Idaho, particularly for underserved communities, including rural populations, individuals with chronic conditions, and seniors. “By expanding programs for caregivers, community health workers, and healthcare providers, we can…
KalVista Pharmaceuticals Shares Sebetralstat Data at 2024 HAEi Forum
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) announced that it presented data demonstrating the effectiveness of sebetralstat in reducing anxiety during hereditary angioedema (HAE) attacks at the HAEi Global Angioedema Forum (GAF) in Copenhagen, Denmark, on October 4-5, 2024. This data, derived…